Mitochondrial neurogastrointestinal encephalomyopathy
MONDO:0017575A syndrome characterized by the association of gastrointestinal dysmotility, peripheral neuropathy, chronic progressive external ophthalmoplegia and leukoencephalopathy.
Also known as: MNGIE, Mitochondrial Neurogastrointestinal Encephalopathy, Mitochondrial neurogastrointestinal encephalopathy, mitochondrial Neurogastrointestingal encephalopathy, MNGIE syndrome, OGIMD, POLIP, mitochondrial neurogastrointestinal encephalopathy syndrome
26 clinical trials for this condition and its sub-types, 4 tagged with Mitochondrial neurogastrointestinal encephalomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Mitochondrial neurogastrointestinal encephalomyopathy
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple blood test track nerve damage? a study investigates NT-3 levels in neuropathy.
Knowledge-focused Stopped earlyThis study measures levels of a protein called NT-3 in the blood of people with peripheral neuropathy or Charcot-Marie-Tooth disease. Researchers will compare these levels with measures of muscle strength, mobility, and daily function. The goal is to see whether NT-3 levels corre…
Sponsor: Zarife Sahenk • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC